Anti HBsAg refers to antibodies against the hepatitis B surface antigen, indicating immunity to hepatitis B from vaccination or recovery. This blood test detects whether someone has protective antibodies against the virus.
The test measures antibody levels in blood serum. Positive results show immunity, while negative results suggest vulnerability. The test uses enzyme-linked immunosorbent assay (ELISA) technology for accurate detection.
| Test Type | Purpose | Result Interpretation |
|---|---|---|
| HBsAg | Detects surface antigen | Positive indicates current infection |
| Anti-HBs | Detects surface antibody | Positive indicates immunity |
| Anti-HBc | Detects core antibody | Positive indicates past infection |
Healthcare professionals use this test to confirm vaccine effectiveness and assess immune status. The Centers for Disease Control and Prevention recommends testing after vaccination completion to verify protection.
During my work at a community health clinic, I saw firsthand how this test helped identify individuals who needed booster shots. One patient, initially negative, received the full vaccine series and later tested positive for anti-HBsAg, confirming their immunity.
Many confuse anti-HBsAg with HBsAg. While HBsAg indicates active infection, anti-HBsAg shows immunity. A positive anti-HBsAg result doesn't mean current infection but rather protection.
Another misunderstanding involves test timing. Anti-HBsAg appears 1-2 months after vaccination or infection resolution, not immediately. Testing too soon may yield false negatives.
Medical professionals recommend testing:
The World Health Organization estimates 296 million people have chronic hepatitis B infections, highlighting the importance of screening and prevention.